Latest International Expansion News

Page 3 of 56
Airtasker’s Australian marketplace reached a record $57.3 million in first-quarter GMV, while paid subscribers more than doubled in three months. The company reaffirmed FY27 guidance as international growth continued, though seasonal weakness is expected in the UK and US.
Victor Sage
Victor Sage
15 Oct 2026
BLS Pharmaceuticals has opened FY27 with record quarterly revenue, positive operating cash flow and reaffirmed full-year guidance. The report contains conflicting Q1 revenue figures of $26.7 million and $27.5 million, while its Scotland expansion remains subject to regulatory approval.
Victor Sage
Victor Sage
15 Oct 2026
Qualitas delivered record deployment and stronger earnings in FY26, while raising its dividend and entering Europe through the Starz Real Estate acquisition. The alternative investment manager is guiding to normalised NPBT of $74 million to $80 million for FY27, subject to market conditions.
Claire Turing
Claire Turing
14 Oct 2026
XRF Scientific has delivered its strongest September quarter in years, with revenue rising 38% to $21.1 million and profit before tax climbing 30% to $4.4 million. Orbis growth, resilient consumables demand and the developing CGA business are giving the company several avenues for further expansion, although precious metals revenue included a low-margin one-off sale.
Victor Sage
Victor Sage
13 Oct 2026
Ionic Rare Earths has moved its Belfast magnet recycling project closer to construction while expanding into the United States through a proposed US$100 million joint venture. The progress comes with key funding, approvals and definitive agreements still outstanding.
Victor Sage
Victor Sage
13 Oct 2026
Firebrick Pharma has raised approximately $732,000 from strategic investors, with its Philippines licensing partner investing $631,750 to lift its holding above 10%. The funding will support US retail production, a Singapore product launch and working capital.
Ada Torres
Ada Torres
12 Oct 2026
ECS Botanics is taking six Australian-grown medicinal cannabis flower products into the UK through Curaleaf Laboratories, with initial supply targeted for November. The two-year deal offers access to UK sell-through but no guaranteed volumes, revenue or minimum purchases.
Victor Sage
Victor Sage
7 Oct 2026
Stakk has secured a new IBM contract covering AI-powered document processing across Australia and New Zealand, with revenue contribution starting immediately. The agreement runs to September 2027, but its financial value remains unquantified because it depends on processing volumes.
Victor Sage
Victor Sage
6 Oct 2026
Eden Innovations reported a sharp acceleration in US sales during Q1 FY27, led by a 247% jump in OptiBlend revenue and expanding EdenCrete plant installations. The figures are unaudited management results, but they give the company a stronger opening quarter for the new financial year.
Victor Sage
Victor Sage
6 Oct 2026
Pure One Corporation Limited (ASX:P1E) reported FY26 net profit after tax of A$5.070 million, alongside A$7.191 million in cash and term deposits. The company is positioning battery-swappable heavy vehicles and electric vans as its growth engine, while retaining sizeable interests in gas and clean-energy ventures.
Victor Sage
Victor Sage
30 Sept 2026
Felix Group Holdings grew FY26 revenue and contracted ARR after acquiring Nexvia, but operating losses and cash outflows widened sharply. The ASX-listed software company is now relying on a post-year-end capital raising while it narrows its strategy to Australia and New Zealand.
Sophie Babbage
Sophie Babbage
30 Sept 2026
Cann Group’s FY2026 profit was transformed by a one-off A$55.7 million debt-forgiveness gain, while a leaner cost base and new export sales offered more durable progress. The company remains loss-making on a normalised basis and dependent on lender waivers and a future refinancing.
Victor Sage
Victor Sage
30 Sept 2026

Browse the archive

Full archive